7.94
-0.24(-2.93%)
Currency In USD
| Previous Close | 8.18 |
| Open | 8.2 |
| Day High | 8.25 |
| Day Low | 7.79 |
| 52-Week High | 13.24 |
| 52-Week Low | 3.92 |
| Volume | 339,101 |
| Average Volume | 387,896 |
| Market Cap | 497.19M |
| PE | -8.82 |
| EPS | -0.9 |
| Moving Average 50 Days | 9.07 |
| Moving Average 200 Days | 7.1 |
| Change | -0.24 |
If you invested $1000 in Treace Medical Concepts, Inc. (TMCI) since IPO date, it would be worth $311.01 as of March 14, 2025 at a share price of $7.94. Whereas If you bought $1000 worth of Treace Medical Concepts, Inc. (TMCI) shares 3 years ago, it would be worth $448.59 as of March 14, 2025 at a share price of $7.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Treace to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
GlobeNewswire Inc.
Feb 06, 2025 9:15 PM GMT
PONTE VEDRA, Fla., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces First Surgical Cases Utilizing the SpeedAkin™ Anatomic Compression Implant
GlobeNewswire Inc.
Jan 30, 2025 1:00 PM GMT
PONTE VEDRA, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2024 Revenue
GlobeNewswire Inc.
Jan 13, 2025 1:00 PM GMT
PONTE VEDRA, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot defor